Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, has released its third-quarter 2021 revenues, which are lower than expected. In the report, the company observed that the U.S. Food and Drug Administration’s (“FDA”) Premarket Tobacco Application (“PMTA”) process has impacted its revenues. The company noted that it believes many retailers and distributors have been reluctant to take on new inventory because they were concerned about being left with inventory that, as a result of the PMTA, would be illegal to sell. The company also noted that other retailers may have purchased counterfeit or suboptimal products at significantly reduced prices. According to the announcement, these circumstances have resulted in a challenging third quarter. The company reported revenues of $3.4 million for the three months ended July 31, 2021, compared to $32.4 million for the three months ended July 31, 2020; KAVL also reported revenues of $59.5 million for the nine months ended July 31, 2021, compared to $54.9 million for the nine months ended July 31, 2020. The company also noted that it has lowered its internal revenue expectations for the year ending Oct. 31 , 2021. “While our third-quarter revenue results did not meet our expectations, we remain steadfast in our commitment to preventing youth use of ENDS, responsibly marketing to adult tobacco users 21 and over, working with law-abiding retailers and distributors, and complying with all federal and state laws and taxes applicable to the distribution of the BIDI(R) Stick including but not limited to the Family Smoking Prevention and Tobacco Control Act; the Food, Drug and Cosmetic Act; and the Prevent All Cigarette Trafficking Act,” said Kaival Brands founder and CEO Niraj Patel in the press release. “Since inception, we, together with Bidi Vapor, have been built upon the foundations of industry-and-regulatory exceeding compliance standards. Over the past 12 months, together we have been preparing for a post-PMTA regulatory environment and have maintained our focus on providing an industry-leading premium vape experience along with establishing industry-best youth access prevention programs and protocols. We believe that the delay in the distribution of the BIDI Pouch in the U.S. will lower revenues in the short term. However, we believe that in the longer term, the removal of all synthetic nicotine products in the U.S. market could prove to be a positive event for us.”
To view the full press release, visit https://ibn.fm/T87gu
About Kaival Brands Innovations Group Inc.
Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor. For more information about the company, visit www.KaivalBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
